C57BL/6JGpt-Mettl3em1Cflox/Gpt

Mouse Model: Mettl3-flox
Strain Number: T006659

Conditional knockout (cKO)

  • Product Type:
  • Quantity: - +
  • Sex:
  • Age:
  • Genotype:

GemPharmatech Offers the World’s Largest Knockout and Conditional Knockout Library

With over 25,000 mouse models available and thousands of new strains developed annually, GemPharmatech has built the world’s largest knockout and conditional knockout resource library. Every model is generated using cutting-edge gene editing and validated at the genomic level to ensure reliability. Choosing GemPharmatech means more than acquiring a mouse model, it means partnering with a global leader committed to scientific rigor, competitive pricing, and timely delivery of the mice models your research requires.

BASIC INFORMATION
Strain Name: C57BL/6JGpt-Mettl3em1Cflox/Gpt
Strain Number: T006659
Official Symbol: Mettl3
Strain Strategy: T006659. Mettl3 Cas9-CKO Strategy-EN.pdf
Official Full Name: methyltransferase like 3
Also Known As: 2310024F18Rik,M6A,Spo8
NCBI Number: 56335
MGI Number: 1927165
Chromosome: 14
Distance Between Two Loxps: 2436bp
Research Areas: Metabolic research,Protein metabolism,Developmental Biology,cell differentiation,embryo,growth/size/body,mortality/aging,Cell biology,cell nucleus,Molecular biology,Signal Transduction,RNA binding protein,transferase
Strain Background: [N000013] C57BL/6JGpt
Modification Type: Conditional knockout (cKO)
Genotyping Protocols: T006659.Mettl3 Genotyping Protocol(CKO).pdf
Inventory Status: Live,Cryopreserved
Sale Status: IF (Available for Distribution)
Health Status: Specific pathogen free (SPF)
Health Report: Please log in to view
Publications: 1. Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy. Cell Death Dis (2023)2. Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms. Science translational medicine (2022)3. METTL3-mediated N6-methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication. Theranostics (2022)4. METTL3-Regulated lncRNA SNHG7 Drives MNNG-Induced Epithelial-Mesenchymal Transition in Gastric Precancerous Lesions. Toxics (2024)5. METTL3 governs thymocyte development and thymic involution by regulating ferroptosis. Nat Commun (2024)6. Exercise promotes skeletal muscle growth in adolescents via modulating Mettl3-mediated m6A methylation of MyoD in muscle satellite cells. Cell Mol Biol Lett (2024)7. METTL3 Potentiates M2 Macrophage‐Driven MMT to Aggravate Renal Allograft Fibrosis via the TGF‐β1/Smad3 Pathway. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2025)8. The Impact of METTL3 on MDM2 Promotes Podocytes Injury During Diabetic Kidney Disease. Journal of cellular and molecular medicine (2025)
Gene Family: m6A methyltransferase complexMethyltransferase like

Extend the Value of Your Mouse Models with Integrated Preclinical Services

GemPharmatech not only provides access to advanced genetically engineered mouse models but also offers comprehensive preclinical research services to help you maximize their value. Our scientific team can support your studies from model construction through phenotype validation and pharmacology testing, ensuring that every experiment is designed for translational relevance. By pairing this conditional knockout model with GemPharmatech’s preclinical services, you gain an integrated workflow that accelerates discovery, reduces risk, and produces robust, actionable data.